COMMUNIQUÉS West-GlobeNewswire

Ultragenyx Announces FDA Accepts Proposal to Submit an NDA for UX007 for the Treatment of Long-Chain Fatty Acid Oxidation Disorders
29/08/2018
NOVATO, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced [...]
Avinger Receives New Patent Covering Pantheris Image-Guided Atherectomy System
29/08/2018
Extensive Intellectual Property Portfolio Now Includes 131 Patents and Applications REDWOOD CITY, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for [...]
Cesca Therapeutics Announces Poster Presentation at the 4th Annual CAR-TCR Summit
29/08/2018
Management Will Also Deliver Spotlight Presentation During the “Tech Slam at the Innovation Hub” RANCHO CORDOVA, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL), a market leader in [...]
Cellectar Biosciences to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
29/08/2018
MADISON, Wis., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the [...]
Biodesix Confirms Prognostic Value of VeriStrat Testing in Phase 3 Study of Patients with Advanced Lung Cancer
29/08/2018
The Oncologist Publishes Results of 1,048 Patient Study BOULDER, Colo., Aug. 29, 2018 (GLOBE NEWSWIRE) -- A new study published in The Oncologist demonstrates the objective prognostic value of the Biodesix VeriStrat ® [...]
Cambrex to Present at Upcoming Investor Conferences in September
29/08/2018
EAST RUTHERFORD, N.J., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that [...]
Genocea to Present at Two September Investor Conferences
29/08/2018
CAMBRIDGE, Mass., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that Chip Clark, president and chief [...]
Avid Bioservices to Present at Upcoming Investor Conferences
29/08/2018
TUSTIN, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
Catalyst Pharmaceuticals to Present at Rodman & Renshaw’s 20th Annual Global Investment Conference
29/08/2018
CORAL GABLES, Fla., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]
Endocyte to Present at Wells Fargo Securities 2018 Healthcare Conference
29/08/2018
WEST LAFAYETTE, Ind., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company’s [...]
Iovance Biotherapeutics to Present at Two Investor Conferences in September
29/08/2018
SAN CARLOS, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology [...]
Evolus Receives Acceptance of FDA BLA Resubmission for DWP-450
29/08/2018
Application Designated as Class 2 by U.S. FDA and Assigned February 2, 2019 PDUFA Date IRVINE, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today [...]
Kezar Life Sciences to Present at 2018 Wells Fargo Healthcare Conference
29/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet [...]
Fibrocell to Present at 20th Annual Rodman & Renshaw Global Investment Conference
29/08/2018
EXTON, Pa., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]
Jounce Therapeutics to Present at Upcoming Investor Conferences in September
29/08/2018
CAMBRIDGE, Mass., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, [...]
Ovid Therapeutics to Present at Two Investor Healthcare Conferences in September 2018
29/08/2018
NEW YORK, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]
Diffusion Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
29/08/2018
CHARLOTTESVILLE, Va., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on improving patient outcomes in unmet [...]
Bio-Path Holdings to Present at the H.C. Wainwright 20th Annual Global Investment Conference
29/08/2018
HOUSTON, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]
Proteon Therapeutics to Present at Two Upcoming Investor Conferences
29/08/2018
WALTHAM, Mass., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]

Pages